Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults
Clinical trial NCT04439695 · COMPLETED
Trial details
- NCT number
- NCT04439695
- Sponsor
- KBio Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-25
- Primary completion
- 2021-02-25
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.